Financing round · Healthtech
HighLife raises €80m for European commercialization and U.S. pivotal study
Andera Partners, Sofinnova Partners, Mérieux Equity Partners and Supernova Invest co-led the financing.
HighLife raised €80 million in financing co-led by Andera Partners, Sofinnova Partners, Mérieux Equity Partners and Supernova Invest.
The company will accelerate European commercial expansion and advance its U.S. pivotal clinical program for transcatheter mitral-valve replacement. The U.S. study is a planned development milestone.
Additional participants
An unnamed global strategic investor also participated in the financing.
Use of funds
Accelerate commercial expansion across Europe
Advance the US pivotal clinical development program
Funding history
Financing round · This round€80M